| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |